Gene · 6317
Papers2,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma. | Cancers (Basel) | 2024 | 38201652 | PubTator, text mining | PubMed |
| The clinical characteristics of non-cystic fibrosis bronchiectasis patients with positive serum tumor markers: a retrospective study. | BMC Pulm Med | 2024 | 38191360 | PubTator, text mining | PubMed |
| Tea seed saponin‑reduced extract ameliorates palmitic acid‑induced insulin resistance in HepG2 cells. | Mol Med Rep | 2024 | 38099345 | PubTator, text mining | PubMed |
| WTAP-Mediated N6-Methyladenosine of RNAs Facilitate the Pathophysiology of Atopic Dermatitis. | J Invest Dermatol | 2024 | 38029838 | PubTator, text mining | PubMed |
| The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation. | Aliment Pharmacol Ther | 2024 | 37990490 | PubTator, text mining | PubMed |
Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review. | Ann Surg Oncol | 2024 | 37777688 | PubTator, text mining | PubMed |
| Impact of anti-squamous cell carcinoma antigen antibodies on serum squamous cell carcinoma antigen levels measured by chemiluminescent immunoassay and chemiluminescent enzyme immunoassay. | Lab Med | 2024 | 37706549 | PubTator, text mining | PubMed |
| Combined use of NK cells and radiotherapy in the treatment of solid tumors. | Front Immunol | 2023 | 38264648 | PubTator, text mining | PubMed |
| Mature Cystic Teratoma of the Ovary Transforms into Squamous Cell Carcinoma: A Case Report. | J Menopausal Med | 2023 | 38230600 | PubTator, text mining | PubMed |
The vicious cycle of family dysfunction and problematic gaming and the mediating role of self-concept clarity among early adolescents: A within-person analysis using random intercept cross-lagged panel modeling. | J Behav Addict | 2023 | 38141062 | PubTator, text mining | PubMed |
| Changes in serum tumor markers in type 2 diabetes mellitus with microalbuminuria. | Front Endocrinol (Lausanne) | 2023 | 38130399 | PubTator, text mining | PubMed |
| Incidence and risk factors of lymph node metastasis in breast cancer patients without preoperative chemoradiotherapy and neoadjuvant therapy: analysis of SEER data. | Gland Surg | 2023 | 38107495 | PubTator, text mining | PubMed |
| Inhibitory effects of the nanoscale lysate derived from xenogenic dental pulp stem cells in lung cancer models. | J Nanobiotechnology | 2023 | 38105218 | PubTator, text mining | PubMed |
| Cell Type Catalog of Middle Turbinate Epithelium (Cell Catalog of Turbinate Epithelium). | OTO Open | 2023 | 38093720 | PubTator, text mining | PubMed |
| Autophagy and Senescence: The Molecular Mechanisms and Implications in Liver Diseases. | Int J Mol Sci | 2023 | 38069199 | PubTator, text mining | PubMed |
| Effects of a return to work program on the health and barriers to returning to work in head and neck cancer patients: A randomized controlled trial. | Asia Pac J Oncol Nurs | 2023 | 38059206 | PubTator, text mining | PubMed |
| Comparative genomics reveals the correlations of stress response genes and bacteriophages in developing antibiotic resistance of Staphylococcus saprophyticus. | mSystems | 2023 | 38051037 | PubTator, text mining | PubMed |
| TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis. | Cell Death Discov | 2023 | 38040698 | PubTator, text mining | PubMed |
| Impact of COPD pulmonary structural remodeling on the prognosis of patients with advanced lung squamous cell carcinoma. | Heliyon | 2023 | 38027974 | PubTator, text mining | PubMed |
| Effectiveness of a universal personalized intervention for the prevention of anxiety disorders: Protocol of a randomized controlled trial (the prevANS project). | Internet Interv | 2023 | 38023964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6317/papers?page=7